GW Wins Contract to Develop Antidote-Bearing Organisms to Protect Against Biological, Chemical Threats

GW researchers will use CRISPR/Cas9 technology to genetically modify commensal organisms to help neutralize threats experienced by warfighters and first responders
Press Releases

The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.

Press Release

Latest News

Illustration of work conducted by professors Paul J. Brindley, PhD, and Wannaporn Ittiprasert Tanno, PhD
GW Researchers Develop Model to Study Neglected Tropical Diseases
Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference
Dr. Bukrinsky's recent paper titled "Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells" was published in Cell Reports and mentioned in TheScientist news outlet.
Read the published article here.